STAT

Opinion: ‘Anchoring’ was at work in setting the price of Novartis’ new gene therapy

Novartis tossed out a bunch of prices for Zolgensma that ranged as high as $5 million. Did that make the official price tag of $2.1 million somehow look like a…

If the Empire State Building happened to be hollow, could you fill it with 1 billion ping pong balls? Would that number fall short, or would you have leftovers? How many ping pong balls do you think it would take exactly?

I know, it’s a hard question. It’s hard to know even where to start.

A half a century ago, Nobel laureate Daniel Kahneman and his lifelong colleague Amos Tversky described . When offered a number

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
Opinion: STAT+: Unmasking The ‘Centricity’ Illusion In Clinical Trials
The glacial pace of change in mechanistic but essential areas of clinical trials undermines the biopharma industry's claims of progress and compassion.
STAT1 min read
STAT+: Pharmalittle: We’re Watching A Cytokinetics Deal With Royalty Pharma, Cue Health Shutting Down, And More
Cytokinetics did a deal with Royalty Pharma, the biotech firm that has become a huge success by buying up small shares of other companies’ drugs.
STAT1 min read
STAT+: Wearable Devices Generate Powerful Data But It’s Not Useful To Doctors, Yet
Data from wearables can be powerful but they're not useful to doctors yet, experts said at the #STATBreakthrough Summit in San Francisco.

Related Books & Audiobooks